Pridinol Methanesulfonate is a centrally acting muscle relaxant and anticholinergic agent of the piperidine class, primarily indicated for the management of Parkinson’s disease symptoms and the treatment… Read more
Pridinol Methanesulfonate is a centrally acting muscle relaxant and anticholinergic agent of the piperidine class, primarily indicated for the management of Parkinson’s disease symptoms and the treatment of skeletal muscle tension or spasms. This category provides essential reference standards for the parent active pharmaceutical ingredient, alongside its known impurities, metabolites, and stable isotope labelled compounds. These high-quality materials are critical for analytical laboratories during method validation, quality control testing, and impurity profiling. By serving as reliable benchmarks, these standards enable accurate identification and quantification of the drug and its related substances in complex matrices, often supporting LC-MS/MS and HPLC applications. Whether conducting stability studies, routine batch analysis, or research into drug degradation pathways, laboratories rely on these characterized compounds to ensure analytical precision and regulatory compliance throughout the pharmaceutical development lifecycle.